A Phase 1b, Open-Label, Multiple Ascending Dose Study to Investigate the Safety and Tolerability of OSA-1-100 Intravitreal Implant in Subjects with Dry Age-Related Macular Degeneration (AMD)
Research Grant
Awarded By
Osanni Bio, Inc.
Start Date
May 1, 2024
End Date
November 30, 2025
Awarded By
Osanni Bio, Inc.
Start Date
May 1, 2024
End Date
November 30, 2025